Cite
Amin AM, Sheau Chin L, Azri Mohamed Noor D, et al. The Personalization of Clopidogrel Antiplatelet Therapy: The Role of Integrative Pharmacogenetics and Pharmacometabolomics. Cardiol Res Pract. 2017;2017:8062796doi: 10.1155/2017/8062796.
Amin, A. M., Sheau Chin, L., Azri Mohamed Noor, D., Sk Abdul Kader, M. A., Kah Hay, Y., & Ibrahim, B. (2017). The Personalization of Clopidogrel Antiplatelet Therapy: The Role of Integrative Pharmacogenetics and Pharmacometabolomics. Cardiology research and practice, 20178062796. https://doi.org/10.1155/2017/8062796
Amin, Arwa M, et al. "The Personalization of Clopidogrel Antiplatelet Therapy: The Role of Integrative Pharmacogenetics and Pharmacometabolomics." Cardiology research and practice vol. 2017 (2017): 8062796. doi: https://doi.org/10.1155/2017/8062796
Amin AM, Sheau Chin L, Azri Mohamed Noor D, Sk Abdul Kader MA, Kah Hay Y, Ibrahim B. The Personalization of Clopidogrel Antiplatelet Therapy: The Role of Integrative Pharmacogenetics and Pharmacometabolomics. Cardiol Res Pract. 2017;2017:8062796. doi: 10.1155/2017/8062796. Epub 2017 Mar 21. PMID: 28421156; PMCID: PMC5379098.
Copy
Download .nbib